Related Experiment Video
Updated: May 15, 2026
12:39
Maximum Isometric Tetanic Force Measurement of the Tibialis Anterior Muscle in the Rat
Published on: June 26, 2021
FK506 and nerve regeneration: past, present, and future
Petros Konofaos1, Julia K Terzis
1Department of Plastic Surgery, University of Tennessee, Memphis, TN 38105, USA. petros_konofaos@yahoo.com
Journal of Reconstructive Microsurgery
|January 17, 2013
Summary
The immunosuppressive drug FK506 shows promise for neurological recovery by protecting neurons and promoting axon regeneration. This agent could aid in managing severe peripheral nerve injuries for better outcomes.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Pharmacology
Background:
- Neurological recovery necessitates protecting neurons and enhancing axon regeneration.
- Peripheral nerve injuries require agents to accelerate reinnervation.
- FK506 (also known as Tacrolimus) exhibits neuroprotective and neurotrophic properties.
Purpose of the Study:
- To review the role of FK506 in promoting neurological recovery.
- To focus on FK506's neurotrophic effects.
- To assess FK506's potential clinical application for peripheral nerve injuries.
Main Methods:
- Literature review of experimental models.
- Analysis of FK506's effects on neurite elongation.
- Evaluation of FK506's impact on nerve regeneration rates in vitro and in vivo.
Main Results:
- FK506 demonstrates neuroprotective actions.
- FK506 enhances neurite elongation.
- FK506 accelerates nerve regeneration speed and extent.
Conclusions:
- FK506 acts as a potent neurotrophic agent.
- FK506 has significant potential for clinical use in treating peripheral nerve injuries.
- FK506 may promote faster and more extensive neurological recovery.
